secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001193125-23-067531
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CytomX says SVB exposure immaterial; cash near FDIC limit, $917K letter of credit
--------------------------------------------------------------------------------

- Operating cash at SVB at or near FDIC-insured limit of $250,000.
- Standby letter of credit under office lease: ~$917,000 deposited at SVB.
- Third-party investments held at outside custodians, not directly exposed to SVB.
- Company does not consider SVB liquidity concern material to its operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312523067531/0001193125-23-067531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312523067531/d280737d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-067531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer